Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 23;18(1):550–558. doi: 10.3892/etm.2019.7601

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Wu et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 6. — Altered expression of miR-620 and DCTD contributes to gemcitabine resistance in patients with TNBC. (A) Compared with tumor tissues from patients with gemcitabine-sensitive TNBC, miR-620 expression levels were elevated in tumor tissues from patients with gemcitabine-resistant TNBC. (B) DCTD expression levels were increased in tumor tissues from patients with gemcitabine-resistant TNBC patients. (C) A negative correlation between miR-620 and DCTD mRNA expression levels in tumor tissues from patients with TNBC. **P<0.01 and ***P<0.001 vs. gemcitabine-sensitive. TNBC, triple negative breast cancer; miR, microRNA; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.